ML18037A884: Difference between revisions
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 3: | Line 3: | ||
| issue date = 02/06/2018 | | issue date = 02/06/2018 | ||
| title = Nwmi Commission Hearing Exhibit List - Revision 2 | | title = Nwmi Commission Hearing Exhibit List - Revision 2 | ||
| author name = Haass | | author name = Haass C | ||
| author affiliation = Northwest Medical Isotopes, LLC | | author affiliation = Northwest Medical Isotopes, LLC | ||
| addressee name = | | addressee name = | ||
| Line 16: | Line 16: | ||
=Text= | =Text= | ||
{{#Wiki_filter:Exhibit List-R2 | {{#Wiki_filter:Exhibit List-R2 UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE COMMISSION | ||
}} | ) | ||
In the Matter of ) Docket No. 50-609-CP | |||
) | |||
NORTHWEST MEDICAL ISOTOPES, LLC ) | |||
) | |||
(Medical Radioisotope Production Facility) ) February 6, 2018 | |||
) | |||
EXHIBIT LIST (REVISION 2) | |||
NORTHWEST MEDICAL ISOTOPES, LLC EVIDENTIARY HEARING In accordance with the Commissions notice dated November 21, 2017 and Scheduling Order dated January 9, 2018, Northwest Medical Isotopes, LLC (NWMI) hereby submits its updated list of exhibits for the evidentiary hearing for Docket No. 50-609-CP held on January 23, 2018 (Revision 2). The updated list includes Exhibit NWMI-012, NWMIs response to the Commissions January 30, 2018 post-hearing questions regarding the mandatory hearing for the Construction Permit Application for NWMIs medical radioisotope production facility. | |||
Below is a crosswalk identifying the NWMI Exhibit number with the corresponding Sponsoring Witness(es) and Document Title. | |||
Exhibit Panel Number/ | |||
Number Sponsoring Witness(es) Document Description/Title NWMI-001-R Carolyn C. Haass Northwest Medical Isotopes, LLC Responses to Commissions Public Pre-Hearing Questions NWMI-002-R Carolyn C. Haass Northwest Medical Isotopes, LLC Responses to Commissions Non- Public Pre-Hearing Questions Exhibit List (Docket No. 50-609-CP) 1 | |||
Exhibit List-R2 Exhibit Panel Number/ | |||
Number Sponsoring Witness(es) Document Description/Title NWMI-003-R Statement of Qualifications: Statement of Qualifications in Support of Roy W. Brown, Ralph A. Butler, Northwest Medical Isotopes, LLC Medical Michael R. Corum, Gary L. Dunford, Radioisotope Production Facility Construction Nicholas F. Fowler, Carolyn C. Haass, Permit Application Steve R. Reese NWMI-004-R Overview Panel: Roy W. Brown, Northwest Medical Isotopes, LLC Nicholas F. Fowler, Carolyn C. Haass, Presentation Slides: Overview Presentation Steve R. Reese NWMI-005-R Safety Panel 1: Ralph A. Butler, Northwest Medical Isotopes, LLC Michael R. Corum, Gary L. Dunford, Presentation Slides: Safety 1 Presentation Carolyn C. Haass, Steve R. Reese NWMI-006-R Safety Panel 2: Michael R. Corum, Northwest Medical Isotopes, LLC Gary L. Dunford, Carolyn C. Haass, Presentation Slides: Safety 2 Presentation Steve R. Reese NWMI-007-R Environmental Panel: Michael R. Northwest Medical Isotopes, LLC Corum, Gary L. Dunford, Carolyn C. Presentation Slides: Environmental Haass, Steve R. Reese Presentation NWMI-008 Letters of Support: U.S. Senators Federal, State of Missouri, City of Columbia, Ron Wyden and Claire McCaskill; and Boone County letters of support for the Boone County Commissioner construction and operation of the Northwest Dan Atwill; Manager, City of Medical Isotopes, LLC Radioisotope Columbia, Missouri, Mike Mathis; Production Facility Missouri Department of Economic Development, Terrance M. Maglich, Project Manager NWMI-009 Missouri Department of Natural Clean Water Act Section 401 Water Quality Resources Letter to Northwest Medical Certification of Northwest Medical Isotopes, Isotopes, LLC, dated September 15, LLC Facility in Boone County, NUREG-2017 2209/CEK007189 NWMI-010 Northwest Medical Isotopes, LLC Exemption Request Pursuant to 10 CFR Letter (NWMI-LTR-2017-016) to U.S. 70.17, from Requirement of 10 CFR Nuclear Regulatory Commission, dated 70.21(f), Filing, for Northwest Medical December 18, 2017 Isotopes, LLC Radioisotope Production Facility, dated December 18, 2017 NWMI-011-R Carolyn C. Haass Applicants Pre-Filed Testimony of Carolyn C. Haass for the Mandatory Hearing on Uncontested Issues for the Northwest Medical Isotopes, LLC Medical Radioisotope Production Facility NWMI-012 Carolyn C. Haass Northwest Medical Isotopes, LLC Responses to Commissions Public Post-Hearing Questions Exhibit List (Docket No. 50-609-CP) 2 | |||
Exhibit List-R2 Respectfully submitted, Executed in Accord with 10 C.F.R. § 2.304(d) | |||
Carolyn Digitally signed by Carolyn C Haass C Haass Date: 2018.02.06 10:46:23 -07'00' Signed (electronically) by Carolyn C. Haass Carolyn C. Haass Northwest Medical Isotopes, LLC - Chief Operating Officer 815 NW 9th Ave, Suite 256 Corvallis, OR 97330 Phone: 509-430-6921 Email: carolyn.haass@nwmedicalisotopes.com Dated in Denver, Colorado This 6th day of February 2018 Exhibit List (Docket No. 50-609-CP) 3 | |||
Exhibit List-R2 UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE COMMISSION | |||
) | |||
In the Matter of ) Docket No. 50-609-CP | |||
) | |||
NORTHWEST MEDICAL ISOTOPES, LLC ) | |||
) | |||
(Medical Radioisotope Production Facility) ) February 6, 2018 | |||
) | |||
CERTIFICATE OF SERVICE I hereby certify that on this date, a copy of the Exhibit List (Revision 2), Northwest Medical Isotopes, LLC, Evidentiary Hearing and Exhibits NWMI-013 were submitted through the NRC E-filing system. Exhibits NWMI-001-R through NWMI-011-R have not been revised since the original submission. | |||
Respectfully submitted, Executed in Accord with 10 C.F.R. § 2.304(d) | |||
Carolyn Digitally signed by Carolyn C Haass C Haass Date: 2018.02.06 10:46:36 -07'00' Signed (electronically) by Carolyn C. Haass Carolyn C. Haass Northwest Medical Isotopes, LLC - Chief Operating Officer 815 NW 9th Ave, Suite 256 Corvallis, OR 97330 Phone: 509-430-6921 Email: carolyn.haass@nwmedicalisotopes.com Dated in Denver, Colorado this 6th day of February 2018 Certificate of Service (Docket No. 50-609-CP)}} | |||
Latest revision as of 23:55, 21 October 2019
| ML18037A884 | |
| Person / Time | |
|---|---|
| Site: | Northwest Medical Isotopes |
| Issue date: | 02/06/2018 |
| From: | Haass C Northwest Medical Isotopes |
| To: | NRC/OCM |
| SECY RAS | |
| References | |
| Construction Permit Mndtry Hrg, M 50-609-CP, RAS 54214 | |
| Download: ML18037A884 (4) | |
Text
Exhibit List-R2 UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE COMMISSION
)
In the Matter of ) Docket No. 50-609-CP
)
NORTHWEST MEDICAL ISOTOPES, LLC )
)
(Medical Radioisotope Production Facility) ) February 6, 2018
)
EXHIBIT LIST (REVISION 2)
NORTHWEST MEDICAL ISOTOPES, LLC EVIDENTIARY HEARING In accordance with the Commissions notice dated November 21, 2017 and Scheduling Order dated January 9, 2018, Northwest Medical Isotopes, LLC (NWMI) hereby submits its updated list of exhibits for the evidentiary hearing for Docket No. 50-609-CP held on January 23, 2018 (Revision 2). The updated list includes Exhibit NWMI-012, NWMIs response to the Commissions January 30, 2018 post-hearing questions regarding the mandatory hearing for the Construction Permit Application for NWMIs medical radioisotope production facility.
Below is a crosswalk identifying the NWMI Exhibit number with the corresponding Sponsoring Witness(es) and Document Title.
Exhibit Panel Number/
Number Sponsoring Witness(es) Document Description/Title NWMI-001-R Carolyn C. Haass Northwest Medical Isotopes, LLC Responses to Commissions Public Pre-Hearing Questions NWMI-002-R Carolyn C. Haass Northwest Medical Isotopes, LLC Responses to Commissions Non- Public Pre-Hearing Questions Exhibit List (Docket No. 50-609-CP) 1
Exhibit List-R2 Exhibit Panel Number/
Number Sponsoring Witness(es) Document Description/Title NWMI-003-R Statement of Qualifications: Statement of Qualifications in Support of Roy W. Brown, Ralph A. Butler, Northwest Medical Isotopes, LLC Medical Michael R. Corum, Gary L. Dunford, Radioisotope Production Facility Construction Nicholas F. Fowler, Carolyn C. Haass, Permit Application Steve R. Reese NWMI-004-R Overview Panel: Roy W. Brown, Northwest Medical Isotopes, LLC Nicholas F. Fowler, Carolyn C. Haass, Presentation Slides: Overview Presentation Steve R. Reese NWMI-005-R Safety Panel 1: Ralph A. Butler, Northwest Medical Isotopes, LLC Michael R. Corum, Gary L. Dunford, Presentation Slides: Safety 1 Presentation Carolyn C. Haass, Steve R. Reese NWMI-006-R Safety Panel 2: Michael R. Corum, Northwest Medical Isotopes, LLC Gary L. Dunford, Carolyn C. Haass, Presentation Slides: Safety 2 Presentation Steve R. Reese NWMI-007-R Environmental Panel: Michael R. Northwest Medical Isotopes, LLC Corum, Gary L. Dunford, Carolyn C. Presentation Slides: Environmental Haass, Steve R. Reese Presentation NWMI-008 Letters of Support: U.S. Senators Federal, State of Missouri, City of Columbia, Ron Wyden and Claire McCaskill; and Boone County letters of support for the Boone County Commissioner construction and operation of the Northwest Dan Atwill; Manager, City of Medical Isotopes, LLC Radioisotope Columbia, Missouri, Mike Mathis; Production Facility Missouri Department of Economic Development, Terrance M. Maglich, Project Manager NWMI-009 Missouri Department of Natural Clean Water Act Section 401 Water Quality Resources Letter to Northwest Medical Certification of Northwest Medical Isotopes, Isotopes, LLC, dated September 15, LLC Facility in Boone County, NUREG-2017 2209/CEK007189 NWMI-010 Northwest Medical Isotopes, LLC Exemption Request Pursuant to 10 CFR Letter (NWMI-LTR-2017-016) to U.S. 70.17, from Requirement of 10 CFR Nuclear Regulatory Commission, dated 70.21(f), Filing, for Northwest Medical December 18, 2017 Isotopes, LLC Radioisotope Production Facility, dated December 18, 2017 NWMI-011-R Carolyn C. Haass Applicants Pre-Filed Testimony of Carolyn C. Haass for the Mandatory Hearing on Uncontested Issues for the Northwest Medical Isotopes, LLC Medical Radioisotope Production Facility NWMI-012 Carolyn C. Haass Northwest Medical Isotopes, LLC Responses to Commissions Public Post-Hearing Questions Exhibit List (Docket No. 50-609-CP) 2
Exhibit List-R2 Respectfully submitted, Executed in Accord with 10 C.F.R. § 2.304(d)
Carolyn Digitally signed by Carolyn C Haass C Haass Date: 2018.02.06 10:46:23 -07'00' Signed (electronically) by Carolyn C. Haass Carolyn C. Haass Northwest Medical Isotopes, LLC - Chief Operating Officer 815 NW 9th Ave, Suite 256 Corvallis, OR 97330 Phone: 509-430-6921 Email: carolyn.haass@nwmedicalisotopes.com Dated in Denver, Colorado This 6th day of February 2018 Exhibit List (Docket No. 50-609-CP) 3
Exhibit List-R2 UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE COMMISSION
)
In the Matter of ) Docket No. 50-609-CP
)
NORTHWEST MEDICAL ISOTOPES, LLC )
)
(Medical Radioisotope Production Facility) ) February 6, 2018
)
CERTIFICATE OF SERVICE I hereby certify that on this date, a copy of the Exhibit List (Revision 2), Northwest Medical Isotopes, LLC, Evidentiary Hearing and Exhibits NWMI-013 were submitted through the NRC E-filing system. Exhibits NWMI-001-R through NWMI-011-R have not been revised since the original submission.
Respectfully submitted, Executed in Accord with 10 C.F.R. § 2.304(d)
Carolyn Digitally signed by Carolyn C Haass C Haass Date: 2018.02.06 10:46:36 -07'00' Signed (electronically) by Carolyn C. Haass Carolyn C. Haass Northwest Medical Isotopes, LLC - Chief Operating Officer 815 NW 9th Ave, Suite 256 Corvallis, OR 97330 Phone: 509-430-6921 Email: carolyn.haass@nwmedicalisotopes.com Dated in Denver, Colorado this 6th day of February 2018 Certificate of Service (Docket No. 50-609-CP)